%PDF-1.4
%
270 0 obj
<>
endobj
260 0 obj
<>
endobj
259 0 obj
<>stream
Arbortext Advanced Print Publisher 10.0.1465/W Unicode
2024-03-28T07:57:03-07:00
2017-02-16T08:01:55+05:30
2024-03-28T07:57:03-07:00
application/pdf
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Acrobat Distiller 8.1.0 (Windows)
uuid:3e2482e2-cfbd-4541-bd46-fd0f81ddd396
uuid:3ff2b96b-1dd2-11b2-0a00-aa0028ccdaff
endstream
endobj
271 0 obj
<>
endobj
163 0 obj
<>
endobj
256 0 obj
<>
endobj
258 0 obj
<>
endobj
5 0 obj
<>
endobj
147 0 obj
<>
endobj
143 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 144 0 R/Type/Page>>
endobj
353 0 obj
<>stream
HW]sۺ}LE q=q6kN"!#. ~HMLpvWJd\\ؿ(adGJ e\cZ""2+uUEHE%>@osNI"tϜ>w֘mXi.t;9LJQW`1|
H[ 7AHf3dU5I#B`dYyUMp,aD,icRf0$bek